Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Flat-Rate Subscription to Life Science Reports & News Services - Research and Markets

Research and Markets
Posted on: 14 Dec 17

The "Flat-Rate Subscription to La Merie Publishing Reports & News Services" newsletter has been added to Research and Markets' offering.

Flat-Rate Subscription to La Merie Publishing Reports & News Services

A one-year subscription to this service provides access to:

  • All existing La Merie Publishing reports on stock and listed online in the store;
  • All new reports released by La Merie Publishing during the term of the subscription;
  • 50 (weekly) issues of R&D Pipeline News

Among these reports are:

  • Competitor Analysis reports in tabular presentation format;
  • Brief Reports; and
  • Full Reports.

Publishing activities include updates of existing reports as well as release of new reports.

Among La Merie Publishing News & Information Services are:

  • R&D Pipeline News - Technology Edition;
  • R&D Pipeline News - Therapeutic Area Edition.

After purchase of the Flat-Rate Subscription to La Merie Publishing Reports & News Services, credentials to access a dedicated server account with the report archive will be provided by e-mail. New issues of R&D Pipeline News and the R&D and Business Tracking Services will be delivered by e-mail, old issues are archived in the dedicated server account.

Coverage of reports:

La Merie Publishing has a special focus on biologics including, but not limited to:

  • mRNA vaccines & therapeutics
  • Oncolytic viruses
  • Antibody-drug conjugates;
  • Bispecific antibodies including T-cell or NK cell redirecting antibodies
  • CAR & TCR engineered T-cells and NK cells;
  • Immuno-oncology;
  • Biosimilar antibodies and proteins
  • Biosuperior antibodies;
  • Therapeutic proteins;
  • Therapeutic and prophylactic vaccines;
  • Therapeutic peptides.

Reports of the Competitor Analysis Series deliver NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases and technologies provided in a tabular format and fully referenced.

Full Reports and Brief Reports provide in-depth description and analysis of targets, pipelines, companies and technologies.

Examples of Full Reports as of October 2017 are:

  • mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals
  • The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities
  • TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs
  • T-Cell Redirecting Bispecific Antibodies 2016: A competitive landscape analysis of stakeholders, technologies, pipelines and deals

Examples of Brief Reports as of October 2017 are:

  • CD22: a suitable antigen for targeted payload delivery by immunotherapeutics
  • CD123: a paradigmatic target for immunotherapeutic treatment modalities
  • B-Cell Maturation Antigen (BCMA): hot target for emerging treatment modalities

Examples of Competitor Analysis Reports as of October 2017 are:

  • Mesothelin-Targeted Antibodies, Vaccines & T-Cells 2017
  • Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company
  • Tumor Microenvironment Modulation via IDO, TGF-/R, CXCR4, CSF-1R, CD47-SIRPa, Adenosine, STING & Others
  • Biosimilar and Biosuperior Therapeutic Antibodies
  • PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016
  • Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

Examples of Vaccine Reports

  • Clostridium Difficile Vaccines and Therapeutics 2016
  • Respiratory Syncytial Virus (RSV) Antibodies, Vaccines & Antivirals 2017

Examples of Peptide Reports

  • Cancer Peptides
  • Cardiometabolic Peptides
  • Anti-Infective Peptides
  • Cardiovascular Peptides
  • Anti-Inflammatory Peptides

For more information about this newsletter visit

View source version on

Business Wire

Last updated on: 14/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.